Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy

被引：0
作者：
G Eelen
I Vanden Bempt
L Verlinden
M Drijkoningen
A Smeets
P Neven
M R Christiaens
K Marchal
R Bouillon
A Verstuyf
机构：
[1] Laboratorium voor Experimentele Geneeskunde en Endocrinologie (LEGENDO),Department of Pathology
[2] Katholieke Universiteit Leuven,undefined
[3] University Hospital,undefined
[4] Katholieke Universiteit Leuven,undefined
[5] Multidisciplinary Breast Center,undefined
[6] University Hospital,undefined
[7] Katholieke Universiteit Leuven,undefined
[8] CMPG/ESAT,undefined
[9] Katholieke Universiteit Leuven,undefined
来源：
Oncogene | 2008年 / 27卷
关键词：
Brip1; breast cancer; E2F; vitamin D; high grade; HER-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Mutations in the BRCA1-interacting DEAH helicase Brip1 confer an increased risk of breast cancer. In the present study we aimed to unravel the transcriptional control of Brip1 and to determine its expression levels in a set of 101 primary invasive breast carcinomas. Transcription of Brip1 was found to be cell growth-related and controlled by the E2F/retinoblastoma (Rb) pathway through a conserved E2F-responsive site. Repression of Brip1 expression by the cell growth-inhibiting compound 1α,25-dihydroxyvitamin D3 depended on this same E2F-responsive site. In spite of its role as a tumor suppressor, both quantitative reverse transcriptase-PCR analyses and immunohistochemical stainings showed significantly elevated Brip1 expression levels in grade 3 tumors as compared to grade 1 or 2 carcinomas. Furthermore, increased Brip1 transcript levels were found in tumors with an estrogen receptor-negative, progesterone receptor-negative or HER-2-positive status. In conclusion, these data show that Brip1 is a genuine target gene for the E2F/Rb pathway and that elevated expression levels of Brip1 are detected in primary invasive breast carcinomas with unfavorable characteristics.
引用
收藏
页码：4233 / 4241
页数：8
相关论文
共 166 条
  • [21] Chin K(2002)Polygenic susceptibility to breast cancer and implications for prevention J Pathol 198 157-1241
  • [22] DeVries S(2006)Cytogenetic toxicity of antitumor platinum compounds in Fanconi's anemia Nat Genet 38 1239-322
  • [23] Fridlyand J(2003)NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization Breast Cancer Res Treat 78 313-2675
  • [24] Spellman PT(2004)Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions Eur J Cancer 40 2667-37330
  • [25] Roydasgupta R(2005)Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles J Biol Chem 280 37319-6581
  • [26] Kuo WL(2007)The 17q23 amplicon and breast cancer Cancer Res 67 6574-106
  • [27] D'Andrea AD(2006)Molecular portraits of breast cancer: tumour subtypes as distinct disease entities Nat Rev Cancer 6 99-3608
  • [28] Grompe M(1998)Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1, 25-dihydroxyvitamin D Proc Natl Acad Sci USA 95 3603-876
  • [29] Eelen G(2007)The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor/progesterone receptor/HER-2 breast carcinomas Leukemia 21 868-642
  • [30] Gysemans C(2003)Common markers of proliferation Science 302 639-753
12345678910